EPO and anemia (phenotype): Subcutaneous injections of erythropoietin and granulocyte-colony stimulating factor (G-CSF) were used in 7 patients (19.4% of patients who developed anemia) and 10 patients (25.6% of patients who developed leukopenia), respectively.